Applied UV’s Subsidiary Files Patent Application for New Industry Disruptive Integrated Disinfection System for Healthcare Facilities
NEW YORK, NY, March 11, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Applied UV, Inc. (“Applied UV” or the “Company”) (Nasdaq: AUVI), a leader in smart building technology solutions, today announced that its SteriLumen subsidiary has filed a new patent application with the United States Patent and Trademark Office (“USPTO”) entitled "Disinfection System Comprised of Multiple Wavelengths Each Controlled Optimally" with claims pertaining to a method of integrating disinfection systems uniquely designed to optimize environmental cleanliness across different rates of occupancy within healthcare settings, especially operating rooms. Management estimates the annual market size to be in excess of $150M per year with roughly 4,000 operating rooms renovated annually in the United States.
- The demand for effective disinfection methods in healthcare environments, particularly operating rooms, has never been more critical.
- The cornerstone of this novel system is the PURONet Control System, which represents a seamless integration of the best elements of continuous and terminal disinfection methods.
- The PURONet Control System serves as the central nervous system, seamlessly interfacing with the Puro Protect 222 system for safe, continuous disinfection during occupancy, and the Helo LED system for deep, terminal disinfection when spaces are unoccupied.
- This integrated approach underscores Applied UV’s strategic focus on delivering innovative, energy-efficient, and effective disinfection solutions that meet the rigorous demands of modern healthcare environments.